Transformando la práctica clínica del paciente con Cáncer de Pulmón ALK positivo

Previous Page

Next Page

Page Background

Cumulative incidence RATE of CNS progression

(IRC, ITT)

（

ALEX Study

）

Alectinib delayed CNS progression in patients with and

without CNS metastases at baseline compared with crizotinib

Gadgeel SM et al. ESMO 2017 (Abstract 12980)